Just coming to our own in India; confident of growing our US business in next fiscal year: Lupin managementLupin's margin guidance remains around 19.5-20.5%. The company attributes its success to the pivot to complex products, cost-led initiative...
09 Feb, 2024, 09.04 AM IST
What triggered Lupin’s growth spurt & can it be sustained?"From Q2 onwards, we expected to get back to double digit growth and are very happy that it is happening in Q1 itself. The growth year on y...
04 Aug, 2023, 02.00 PM IST
Lupin appoints Spiro Gavaris as president of US generics bizSpiro, who had most recently served as president of Specialty Generics business at Mallinckrodt Pharmaceuticals and the president of US Inj...
08 Dec, 2022, 10.25 PM IST
Lupin to resize portfolio, slash costs in US biz turnaroundIn an interview to ET, CEO Vinita Gupta said the company had already exited a few products filed from its Somerset facility in New Jersey a...
25 May, 2022, 07.30 AM IST
Over 158 applications for generic products pending with USFDA for approval: LupinSharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last ...
20 Jul, 2020, 03.33 PM IST
Buy Lupin, target Rs 815: Shrikant ChouhanBuy Lupin Ltd. at a price target of Rs 815.0 and a stop loss at Rs 775 from entry point.
06 Apr, 2018, 08.12 AM IST
- Buy Lupin, target Rs 880: Gaurav Bissa
Buy Lupin at a price target of Rs 880 and a stop loss at Rs 820 from entry point.
12 Dec, 2017, 07.54 AM IST
Lupin founder DB Gupta, a self made maverick who wanted to take out TB in India, deadGupta is survived by wife and five children (four daughters and a son) Vinita Gupta, the eldest daughter and Nilesh Gupta were handed over ...
27 Jun, 2017, 02.08 PM IST
Lupin looks to launch 25 products in US this fiscalIn the current year, apart from the Gavis portfolio, Fortamet and Glumetza, the company expects to launch products like Minastrin and Epzic...
15 Aug, 2016, 11.35 AM IST
Lupin opens R&D facility to develop inhalation products in USDrug major Lupin today said it has opened a research and development centre for inhalation products in Florida, the US.
07 Aug, 2015, 08.09 PM IST
Lupin looking to enter new product segments, geographies: MD Nilesh GuptaIn order to consolidate its business globally, the Mumbai-based firm has already inked various agreements in the previous fiscal.
29 Jun, 2015, 03.50 PM IST
Debt-free Lupin is ready for big acquisition: Vinita Gupta, CEO"We are a debt-free company with cash in balance and can raise over a billion dollar-and-half," said CEO Vinita Gupta .
31 Jul, 2014, 12.15 PM IST
Scouting for global acquisitions of brands, companies: LupinThe Mumbai-based firm is adopting a three-pronged approach in its acquisition strategy, which also includes the domestic market.
07 Jul, 2013, 01.06 PM IST
- Lupin Q4 net surges nearly three-fold to Rs 408 crore
The net profit of the drug major jumped to Rs 408 crore for the fourth quarter ended March 2013 against Rs 155 crore in the same period pre...
09 May, 2013, 03.58 AM IST
- Lupin to file new drug application for GSK’s $8 bn blockbuster inhaler Advair
Mumbai-based drug maker Lupin Pharma will file an Abbreviated New Drug Application for GSK’s $8-billion dry powder inhaler Advair, said Vin...
26 Jul, 2012, 11.49 AM IST
Vinita Gupta's entrepreneurial drive: Lupin now a big pharma player in the USLupin is now a big pharma player in the US both in generics and brands, thanks to Vinita Gupta's entrepreneurial drive.
28 Aug, 2011, 07.12 AM IST
- GeNext to prescribe new growth formula for Lupin
Desh Bandhu Gupta built Lupin into a $1-billion enterprise, but he will chart the journey to $3 billion and beyond with his two children.
15 May, 2010, 12.14 AM IST